MENU
CNTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Centessa Pharmaceuticals (CNTA) Ownership - Who owns Centessa Pharmaceuticals?
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company... Show more
Profile
Industry
N/A
Address
1 Ashley Road
Phone
+1 617 468-5770
Employees
153
Web
https://www.centessa.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.42B
P/E Ratio
N/A
Total Cash
284.51M
Projected Growth
N/A
Total Debt
118M
Revenue
15M
Risk (Beta)
1.96
Dividend Yield
N/A
Total Cash/Share
2.12
Total Debt/Equity
N/A
Revenue/Share
0.12 USD as % of share price
Fundamentals
CNTA
Capitalization
2.42B
P/E Ratio
N/A
Risk (Beta)
1.96
Dividend Yield
N/A
Total Cash
285M
Total Cash/Share
2.12
Total Debt
118M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.12%
Revenue
15M
ROE
N/A
Book Value
386M
P/B Ratio
7.02
Cash Flow
N/A
Earnings
-1.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
362K
Current Ratio
14.37
Current Revenue Per Employee
174418.61
Dividends Per Share - Security
N/A
EBITDA
-208.73M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-52.30
Shares Held By Institutions
2.04B
Shares Outstanding - Current
134M
Total Liabilities
142M
Total Volume MTD
N/A
Value
N/A
Gain YTD
7.761
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CNTA showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1 Ashley Road
Phone
+1 617 468-5770
Employees
153
Web
https://www.centessa.com